Navigation Links
IMD Companies, Inc. (ICBU) looks to future and adapts
Date:2/6/2013

TAMPA, Fla., Feb. 6, 2013 /PRNewswire/ -- IMD Companies, Inc. (ICBU) has assessed the outlook of healthcare and public wellness given recent developments in both the Government and private domains especially given last year's Supreme Court ruling. With a strategy designed to take advantage of any anticipated changes in the health arena, IMD is moving some resources into the direct to consumer and non-medical sectors.

CEO Bruce Collett said, "ICBU is in direct negotiations focused on incorporating non-medical wellness and weight loss programs, as well as products aimed at these two sectors." The non-medical side of the industry is growing exponentially due to the explosive growth in IT applications and social media.  This new business model helps with lower cost of goods sold and debt issues," Collett concluded.

ABOUT IMD Companies, Inc.

IMD Companies, Inc., (OTC MARKETS:ICBU) is a Florida corporation, engaged in the medical diagnostics and health and fitness industries. Its primary products and services lie in the health and fitness nutraceutical and medical diagnostics services markets. The company has also expanded into the weight-loss industry.  The company delivers its medical diagnostic services on-site at participating medical clinics and physician offices. The nutraceutical supplements, pills, bar and gels will be marketed and distributed through participating clinics and on-line web marketing retail methods.  The company will continue to develop its innovative marketing strategies, including the use of social networking vehicles.

Safe Harbor Statement:

Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

www.imdcompanies.com


'/>"/>
SOURCE IMD Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
2. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
3. Elektas New Radiation Oncology Technology to Shape the Future of Cancer Care
4. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
5. Oakstone Facilitates Future Growth with New Corporate Headquarters
6. Philips Highlights Future Innovations at RSNA 2012 Transformation Lab
7. Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliquas SilverSeal Products and Future Clinical Development
8. Envisioning the Future: Hospitals Fully Integrated with Medical Device Connectivity Solutions
9. Branded Generics in South East Asia: Current and Future Opportunities
10. The Future is Remote: Digital Radiology Revolutionizes the Way X-rays are Processed and Reviewed
11. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Calif. , Dec. 5, 2016 Sanovas, ... technology accelerator, announced today the launch of its wholly owned ... Logo - http://photos.prnewswire.com/prnh/20161202/445250LOGO   Logo - http://photos.prnewswire.com/prnh/20161202/445251LOGO ... ... There ...
(Date:12/5/2016)... 5, 2016  New research by the CVS ... and the U.S. Department of Health and Human ... and Response (ASPR), published online today in ... notifications encourage patients with chronic conditions to refill ... study also affirms that public-private partnerships can facilitate ...
(Date:12/5/2016)... , Dec. 5, 2016 Eisai Inc. ... at the 2016 Annual Meeting of the American Epilepsy ... CIII, is indicated as an adjunctive therapy for the ... secondarily generalized seizures and primary generalized tonic-clonic seizures (PGTC) ... age and older. Please see Important Safety Information for ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty ... newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... magazine’s 2017 Training Top 125 for their industry leading training methods that engage ... recognizes USA as among the global elite in employer-sponsored training and development programs. ...
(Date:12/5/2016)... ... 2016 , ... The Avamere Family of Companies will celebrate ... Care of Puget Sound ; located at 630 S Pearl Street, Tacoma, WA ... recovering from illness or injury with intensive skilled nursing and rehabilitation services. Much ...
(Date:12/5/2016)... Petersburg, Fla. (PRWEB) , ... December 05, 2016 , ... ... concussions have on the growing brains of young athletes. Over the course of three ... the head through unique mouth guards. The mouth guards, equipped with special sensors, will ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... the 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and ... Talamo said, “We are honored to have Amy E. Herman present at this ...
Breaking Medicine News(10 mins):